Literature DB >> 5072718

Implications of amphetamine-induced stereotyped behavior as a model for tardive dyskinesias.

R Rubovits, H L Klawans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5072718     DOI: 10.1001/archpsyc.1972.01750280070012

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  8 in total

1.  Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects.

Authors:  A C Sayers; H R Bürki; W Ruch; H Asper
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

Review 2.  Orofacial dyskinesia. Clinical features, mechanisms and drug therapy.

Authors:  R M Kobayashi
Journal:  West J Med       Date:  1976-10

3.  The specificity of neuroleptic- and methysergide-induced behavioral hypersensitivity.

Authors:  H L Klawans; D J D'amico; P A Nausieda; W J Weiner
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

4.  Dopamine receptor site sensitivity in hyperthyroid guinea pigs: a possible model of hyperthyroid chorea.

Authors:  H L Klawans; C H Goetz; W J Weiner
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

Review 5.  Effect of apomorphine on schizophrenic symptoms.

Authors:  R C Smith; C Tamminga; J M Davis
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

6.  Effect of cholinergic and anticholinergic agents on tardive dyskinesia.

Authors:  H L Klawans; R Rubovits
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-08       Impact factor: 10.154

7.  Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.

Authors:  P Ettigi; N P Nair; S Lal; P Cervantes; H Guyda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-09       Impact factor: 10.154

8.  Cholinergic inhibition of methylphenidate-induced stereotypy: oxotremorine.

Authors:  K L Davis; L E Hollister; J Tepper
Journal:  Psychopharmacology (Berl)       Date:  1978-01-31       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.